Global Generics industry profile
provides top-line qualitative and quantitative summary information including:
market size (value and volume 2012-16, and forecast to 2021). The profile also
contains descriptions of the leading players including key financial metrics
and analysis of competitive pressures within the market.
Essential resource for top-line
data and analysis covering the Global
Generics Market. Includes market size data, textual and graphical
analysis of market growth trends and leading companies.
For the purposes of this profile, a
generic is defined as a copy of an ethical (prescription) drug formerly
protected by patents that have now expired. Both unbranded generics and all
branded generics are included. However, off-patent drugs that continue to be
offered by the original manufacturer under the original name, and which form
part of the 'generic-eligible' market, are not included. The market value is
evaluated at ex-factory prices. Market volume is quantified here as the
percentage of the total ethical pharmaceutical market volume in a country or
region which is accounted for by generic drugs. It is therefore a generics
penetration rate measure, not an absolute measure of market volume. Regional
volumes are calculated as weighted averages of countries which make up the
region in question where volume data exists. Please note that any volumes of
"1" (one) or 100% are due to rounding as MarketLine does not believe
that generics will ever fully represent 100% of the medicinal market in any
country or region. All currency conversions were calculated at constant average
annual 2016 exchange rates.
The global generics market had
total revenues of USD311.1bn in 2016, representing a compound annual growth
rate (CAGR) of 9.5% between 2012 and 2016. Market consumption volume increased
with a CAGR of 2.2% between 2012 and 2016, to reach a total of 82.1% of total
pharma volume in 2016. Strong growth will continue in the emerging markets but
worldwide there will be a deceleration.
Save time carrying out entry-level
research by identifying the size, growth, and leading players in the global
generics market Use the Five Forces analysis to determine the competitive
intensity and therefore attractiveness of the global generics market Leading
company profiles reveal details of key generics market players' global
operations and financial performance Add weight to presentations and pitches by
understanding the future growth prospects of the global generics market with
five year forecasts by both value and volume
To know more, click on the link below:
Related Reports:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
01244230204